Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, S. H.
Right arrow Articles by Park, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, S. H.
Right arrow Articles by Park, S. H.
Related Collections
Right arrow Neoplasia
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, Vol. 92 No. 11 (December 1), 1998: pp. 4287-4295

Generation of Cells With Hodgkin's and Reed-Sternberg Phenotype Through Downregulation of CD99 (Mic2)

Soon Ha Kim, Eun Young Choi, Young Kee Shin, Tae Jin Kim, Doo Hyun Chung, Sung Ik Chang, Noe Kyeong Kim, and Seong Hoe Park

From the Departments of Pathology and Internal Medicine, Seoul National University College of Medicine, Seoul, Korea; the Department of Pathology, Sungkyunkwan University College of Medicine, Suwon, Korea; and the Department of Anatomy and Medical Genetics, Keimyung University, School of Medicine, Taegu, Korea.

Despite the fact that Hodgkin's and Reed-Sternberg (H-RS) cells are morphological hallmarks of Hodgkin's disease (HD), the nature of H-RS cells still remains to be resolved. Here we report that downregulation of CD99 (Mic2) leads to the generation of cells with an H-RS phenotype. IM9 and BJAB B-cell lines that were transfected with an antisense CD99 expression construct showed the morphological and immunological characteristics of H-RS cells such as multinuclearity, expression of CD15, decreased expression of major histocompatibility complex (MHC) class I and CD45RB, and deregulated secretion of cytokines. The reduced expression of CD99 was also confirmed in H-RS cells of patient's lymph nodes and three HD-derived cell lines, L428, KM-H2, and HDLM-2. Moreover, features characteristic of H-RS cells were completely abolished by forced expression of CD99 and by a constitutively active form of Rac, which functions downstream of CD99. We suggest that CD99 molecules play a crucial role in regulating functions and morphology of cells through a Rac-Rho signaling pathway and that the loss of CD99 expression is a significant molecular event to generate H-RS cells.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am J Clin PatholHome page
K.-C. Chang, Y. Chang, D. Jones, and I.-J. Su
Aberrant Expression of Cyclin A Correlates With Morphogenesis of Reed-Sternberg Cells in Hodgkin Lymphoma
Am J Clin Pathol, July 1, 2009; 132(1): 50 - 59.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. H. Lee, S.-H. Kim, L.-H. Wang, Y.-L. Choi, Y. C. Kim, J. H. Kim, T. S. Park, Y.-C. Hong, and Y. K. Shin
Clinical Significance of CD99 Down-Regulation in Gastric Adenocarcinoma
Clin. Cancer Res., May 1, 2007; 13(9): 2584 - 2591.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-J. Byun, I.-K. Hong, E. Kim, Y.-J. Jin, D.-I. Jeoung, J.-H. Hahn, Y.-M. Kim, S. H. Park, and H. Lee
A Splice Variant of CD99 Increases Motility and MMP-9 Expression of Human Breast Cancer Cells through the AKT-, ERK-, and JNK-dependent AP-1 Activation Signaling Pathways
J. Biol. Chem., November 17, 2006; 281(46): 34833 - 34847.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Jaksits, W. Bauer, E. Kriehuber, M. Zeyda, T. M. Stulnig, G. Stingl, E. Fiebiger, and D. Maurer
Lipid Raft-Associated GTPase Signaling Controls Morphology and CD8+ T Cell Stimulatory Capacity of Human Dendritic Cells
J. Immunol., August 1, 2004; 173(3): 1628 - 1639.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
I.-s. Lee, M. K. Kim, E. Y. Choi, A. Mehl, K. C. Jung, M. C. Gil, M. Rowe, and S. H. Park
CD99 expression is positively regulated by Sp1 and is negatively regulated by Epstein-Barr virus latent membrane protein 1 through nuclear factor-{kappa}B
Blood, June 1, 2001; 97(11): 3596 - 3604.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. W. Sohn, Y. K. Shin, I.-S. Lee, Y. M. Bae, Y. H. Suh, M. K. Kim, T. J. Kim, K. C. Jung, W. S. Park, C.-S. Park, et al.
CD99 Regulates the Transport of MHC Class I Molecules from the Golgi Complex to the Cell Surface
J. Immunol., January 15, 2001; 166(2): 787 - 794.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Scotlandi, N. Baldini, V. Cerisano, M. C. Manara, S. Benini, M. Serra, P.-L. Lollini, P. Nanni, G. Nicoletti, G. Bernard, et al.
CD99 Engagement: An Effective Therapeutic Strategy for Ewing Tumors
Cancer Res., September 1, 2000; 60(18): 5134 - 5142.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
E. Riedl, J. Stockl, O. Majdic, C. Scheinecker, K. Rappersberger, W. Knapp, and H. Strobl
Functional Involvement of E-Cadherin in TGF-{beta}1-Induced Cell Cluster Formation of In Vitro Developing Human Langerhans-Type Dendritic Cells
J. Immunol., August 1, 2000; 165(3): 1381 - 1386.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. H. Kim, Y. K. Shin, I.-s. Lee, Y. M. Bae, H. W. Sohn, Y. H. Suh, H. J. Ree, M. Rowe, and S. H. Park
Viral latent membrane protein 1 (LMP-1)-induced CD99 down-regulation in B cells leads to the generation of cells with Hodgkin's and Reed-Sternberg phenotype
Blood, January 1, 2000; 95(1): 294 - 300.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1998 by American Society of Hematology         Online ISSN: 1528-0020